HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New body mass index for predicting prognosis in patients with antineutrophil cytoplasmic antibody-associated vasculitis.

AbstractOBJECTIVES:
Body mass index (BMI) is a known indicator of all-cause mortality. However, conventional BMI does not reflect the three-dimensional human body. To overcome this limitation, a new BMI has been proposed that provides a closer approximation of real human body shape. This study investigated the associations between the new BMI and poor outcomes in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV).
METHOD:
We retrospectively reviewed the medical records of 242 patients with AAV in a single tertiary medical center. Based on the new BMI, the patients were categorized into four groups: underweight (<18.5 kg/m2.5 ), healthy weight (18.5 to <25.0 kg/m2.5 ), overweight (25.0 to <30.0 kg/m2.5 ), and obese (≥30.0 kg/m2.5 ). The association among the new BMI and death, relapse, end-stage renal disease (ESRD) development, cerebrovascular accident, and cardiovascular disease was analyzed.
RESULTS:
The underweight group, according to the new BMI, had higher hazard ratios (HRs) for all-cause mortality (HR: 3.180, 95% confidence interval [CI]: 1.134-8.922, p = 0.028), relapse (HR: 2.141, 95% CI: 1.019-4.368, p = 0.036), and ESRD development (HR: 2.729, 95% CI: 1.190-6.259, p = 0.018) than the healthy weight group. However, according to the conventional BMI, there were no differences in the risks for all poor outcomes between the underweight and healthy weight groups. Multivariate logistic regression analysis demonstrated that being underweight, according to the new BMI, was an independent risk factor for all-cause mortality (HR: 5.285; 95% CI: 1.468-19.018; p = 0.011).
CONCLUSION:
Being underweight, according to the new BMI, is associated with poor outcomes in patients with AAV.
AuthorsJung Y Pyo, Sung S Ahn, Lucy E Lee, Jason J Song, Yong-Beom Park, Sang-Won Lee
JournalJournal of clinical laboratory analysis (J Clin Lab Anal) Vol. 36 Issue 5 Pg. e24357 (May 2022) ISSN: 1098-2825 [Electronic] United States
PMID35312104 (Publication Type: Journal Article)
Copyright© 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.
Chemical References
  • Antibodies, Antineutrophil Cytoplasmic
Topics
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (epidemiology)
  • Antibodies, Antineutrophil Cytoplasmic
  • Body Mass Index
  • Female
  • Humans
  • Kidney Failure, Chronic
  • Male
  • Prognosis
  • Recurrence
  • Retrospective Studies
  • Thinness (complications, epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: